Navigation Links
SIMPONI(TM) (golimumab) Receives FDA Approval as First Once-Monthly Anti-TNF for Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
Date:4/24/2009

oward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 28, 2008. Copies of this Form 10-K, as well as subsequent filings, are available online at www.sec.gov, www.jnj.com or on request from Johnson & Johnson. Neither Centocor Ortho Biotech Inc. nor Johnson & Johnson undertake to update any forward-looking statements as a result of new information or future events or developments.)


'/>"/>
SOURCE Centocor Ortho Biotech Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine news :

1. Medarex to Receive Milestone Payment for Approval of SIMPONI(TM) for the Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis
2. Lake Elsinore Family Caregiver Receives Free Power Wheelchair From The SCOOTER Store
3. DaVita Receives Civil Complaint
4. Ranbaxy Receives Tentative Approval to Manufacture and Market Galantamine Tablets on an Exclusive Basis
5. Watson Receives First FDA Approval for Manufacturing Product at Its Goa, India Facility
6. Edwards Lifesciences Receives CE Mark for Edwards SAPIEN Transcatheter Heart Valve
7. PainCare Receives $14.4 Million in Cash From Completed Sale of South Florida Ambulatory Surgery Centers
8. UT Southwesterns obesity research receives $22 million NIH Roadmap grant
9. Temple Emergency Medicine receives $1.8M to find best MRSA treatment
10. Prime Therapeutics Receives TIPPS Certification
11. Bioniche Receives $2 Million Government Grant For Market Development Related to its E. coli O157:H7 Cattle Vaccine
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/23/2014)... (HealthDay News) -- Close friends have more influence on ... a new study says. "We,ve known for ... influence on individual alcohol use, but there are no ... and the friend group,s influence on those decisions," Jonathon ... Public Health, said in a university news release. ...
(Date:11/23/2014)... SWAccessControl.com's high quality access control power ... company has announced its new collection of power suppliers. ... high quality power suppliers. All the new models come ... offer lasts until Dec. 20, 2014. , SWAccessControl.com has ... been supporting it for a long time. It is ...
(Date:11/23/2014)... November 23, 2014 The FDA is ... Common, **FDAnews On-Demand Webinar**, Dec. 11, 2014 ? Any ... The FDA’s focus on promotional activities is no longer ... Now they're looking at websites, Twitter, journal articles, TV ... for Thursday, Dec. 11, for On-Demand access to Timothy ...
(Date:11/22/2014)... November 23, 2014 Every year AlignLife ... communities. AlignLife experience rapid growth in the Greenville, SC ... unique opportunity. AlignLife of Simpsonville will be ... for their first annual Toy Drive. These six offices ... would support with this year's toy drive. With so ...
(Date:11/22/2014)... A classic black prom dress will never go ... suppliers, has unveiled its new items of black prom ... at a big discount, up to 70% off. People throughout ... new black prom dresses, made with the best materials, can ... of all customers, the company provides these beautiful outfits in ...
Breaking Medicine News(10 mins):Health News:Close Friends May Be Key to Teens' Drinking 2Health News:Cheap Access Control Power Supplies Online Now at SWAccessControl.com, Special Offer Until Dec. 20, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 2Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 3Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 4Health News:FDAnews Announces The FDA is Watching: What Twitter, Tradeshows and TV Have in Common, On-Demand Webinar, Dec. 11, 2014 5Health News:Greenville Area AlignLife Offices Join Together for a Local Toy Drive 2Health News:New Black Prom Dresses from BellasDress.com 2
... ROCKVILLE, Md., Oct. 29 BioReliance Corporation today,appointed ... the,additional post of Interim CEO, following the announced ... addition, BioReliance announced that,three senior executives have joined ... Chief Scientific Officer, David S. Walker as Chief,Financial ...
... Psychology and Explodes Myths of ,Why ... Bad Kids Happen, ... to bad behavior and are more difficult to raise than,others. The notion ... parents have had to bear for decades, placing guilt for,difficult children squarely ...
... of Pediatrics says heart problems in kids have been ... emergency defibrillators now commonly found in airports and other ... arrest victims can also save the lives of children. ... of Pediatrics (AAP), which is reminding its members -- ...
... have found that using a special type of drug ... beta6-TGF-beta pathway prevents a serious side effect of radiation ... of the lungs), thereby extending patients lives and improving ... at the Plenary I session on October 29, 2007, ...
... pioneering effort, Childrens Hospital of Pittsburgh of UPMC and ... forces to launch a new institute designed to advance ... The potential of this initiative has been recognized by ... of $23 million. The gift will help establish the ...
... threats to global health and ... NEW YORK, Oct. 29 The 20th ... in public health. However, the,increased incidence and burden ... the re-emergence of tuberculosis, present critical,health challenges to ...
Cached Medicine News:Health News:BioReliance Appoints Executive Chairman to be Interim CEO and Announces Recent Senior Executive Additions 2Health News:BioReliance Appoints Executive Chairman to be Interim CEO and Announces Recent Senior Executive Additions 3Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 2Health News:Bad Children Can Happen to Good Parents: A Survival Manual for Parents of Difficult Children by Norman E. Hoffman, Ph.D. 3Health News:Defibrillator Use Urged to Save Children's Lives 2Health News:Defibrillator Use Urged to Save Children's Lives 3Health News:Preventing lung scarring may extend lives of lung cancer patients 2Health News:Collaboration to create pediatric research institute 2Health News:Collaboration to create pediatric research institute 3Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 2Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 3Health News:Charlie Rose Science Series to Focus on the Challenge of Researching and Implementing Effective Treatments for Diseases of the Developing World 4
(Date:11/21/2014)... N.J. , Nov. 21, 2014  PTC Therapeutics, Inc. ... the 2014 Legend of Technology Award for Vision, Innovation, and ... Ph.D., Chief Executive Officer. This award recognizes an individual who ... New Jersey for several decades. ... Technology Award," stated Stuart Peltz , Ph.D., CEO of ...
(Date:11/21/2014)... , Nov. 21, 2014 ... European Medicines Agency (EMA) has granted Orphan ... lead product candidate, for the treatment of ... rare, severely disabling genetic disease characterized by ... (flare-ups) and new abnormal bone formation. This ...
(Date:11/21/2014)... , Nov. 20, 2014  Edwards Lifesciences Corporation (NYSE: ... science of heart valves and hemodynamic monitoring, announced today ... 2014 to support a strong launch of Edwards Lifesciences ... and to improve the global communities where its employees ... global corporate giving will exceed $8 million, including more ...
Breaking Medicine Technology:PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 2PTC Therapeutics Announces CEO, Dr. Stuart Peltz Recipient of The New Jersey Technology Council's 2014 Legend of Technology Award 3Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 2Clementia Pharmaceuticals Receives EMA Orphan Medicinal Product Designation for Palovarotene for the Treatment of Fibrodysplasia Ossificans Progressiva 3Edwards Lifesciences Increases Charitable Giving In 2014 To Support Launch Of Every Heartbeat Matters 2
... today,at the Annual Congress of the European Society ... inhibitor DU-176b reduced the incidence,of venous thromboembolism (VTE) ... replacement surgery. There was a,statistically significant dose response ... were low across the groups. DU-176b is being,developed ...
... Sept. 1 Varian, Inc.,(NasdaqGS: VARI) announced ... Captiva(TM) NDLipids is a simple to use, ... including,lysophosphatidylcholines, from biofluids., It is intended ... pharmaceutical and,life science industries performing quantitative and ...
Cached Medicine Technology:Daiichi Sankyo Announces Clinical Study Data for Oral Factor Xa Inhibitor DU-176b 296-Well Filtration Plate From Varian, Inc. Improves Sensitivity and Precision for Trace Bio-Analysis by LC/MS 2
Determination of Reptilase Time.Extracted venom of Bothrops atrox. 20 BU (Batroxobin unit) per vial....
Quantitative determination of Fibrinogen (Clauss Method). Freeze-dried human thrombin (~100NIH units/mL) with heparin inhibitor and calcium....
Determination of Prothrombin Time (PT) by STA Analyzers (ISI~1.3).Freeze-dried rabbit brain thromboplastin with heparin inhibitor....
The CA method used on the Dade Dimension clinical chemistry system is an in vitro diagnostic test intended for the quantitative determination of calcium in serum....
Medicine Products: